Prostate-specific antigen (PSA) is one of the best-known biomarkers for screening, diagnosis, and follow-up of patients for prostate cancer. Owing to several inherent limitations with PSA, various newer blood and urinary-based biomarkers have been evaluated in pursuit of better detection and...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.